Table 3.
- Multivariate regression analysis of the independent significant factors associated with microvascular complications of DM (N=935)
| Factor | AOR | 95% CI | P-value |
|---|---|---|---|
| Age group | |||
| ≤55 years | Ref | ||
| >55 years | 1.764 | 1.320–2.356 | <0.001** |
| National Guard hospital location | |||
| Al Ahsa | 0.410 | 0.267–0.630 | <0.001** |
| Dammam | Ref | ||
| Patient visited an ophthalmology clinic for retinopathy screening | |||
| No | Ref | ||
| Yes | 2.408 | 1.800–3.222 | <0.001** |
| Lifestyle modification | |||
| No | Ref | ||
| Yes | 0.786 | 0.566–1.093 | 0.152 |
| Injection therapy | |||
| No | Ref | ||
| Yes | 2.219 | 1.638–3.006 | <0.001** |
| Second-to-last HbA1c result | 0.949 | 0.875–1.029 | 0.207 |
**
Significant at p<0.05, AOR: adjusted odds ratio, CI: confidence interval, HbA1c: glycated hemoglobin A1c, ref: reference